4//SEC Filing
Zook Anthony P. 4
Accession 0001077183-25-000058
CIK 0001077183other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:06 PM ET
Size
12.2 KB
Accession
0001077183-25-000058
Insider Transaction Report
Form 4
Zook Anthony P.
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Unit
2025-04-01+421,496→ 421,496 totalExercise: $0.00→ Common Stock (421,496 underlying) - Award
Stock Option (Right to Buy)
2025-04-01+729,927→ 729,927 totalExercise: $10.44Exp: 2035-04-01→ Common Stock (729,927 underlying)
Holdings
- 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying) - 11,336
Common Stock
- 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying)
Footnotes (4)
- [F1]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
- [F2]On April 1, 2025, Mr. Zook was granted 729,927 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F4]Once vested, the shares of common stock are not subject to expiration.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001582393
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:06 PM ET
- Size
- 12.2 KB